Would riluzole be efficacious in the new ALS trial design?

Lancet Neurol. 2010 Oct;9(10):949-50; author reply 950-1. doi: 10.1016/S1474-4422(10)70230-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Amyotrophic Lateral Sclerosis / pathology
  • Animals
  • Controlled Clinical Trials as Topic / methods*
  • Controlled Clinical Trials as Topic / trends
  • Humans
  • Pilot Projects
  • Riluzole / therapeutic use*
  • Treatment Outcome

Substances

  • Riluzole